{"transactions":[{"id":2814828,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":141910,"kind":"person","name":"Boucher Brent J.","position":1,"cik":"0001766229","reported_name":"Boucher Brent J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Commercial"}}],"security":"RSUs","published_at":"2021-03-03T17:53:18.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":7315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This RSU award was granted to the Reporting Person on March 1, 2021. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This RSU award was granted to the Reporting Person on March 1, 2021. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2024."}],"balance_after":7315,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7315},"source":{"system":"sec-edgar","filing":"0001209191-21-017154","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919121017154/doc4.xml","form_type":"4"}},{"id":3005515,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":141910,"kind":"person","name":"Boucher Brent J.","position":1,"cik":"0001766229","reported_name":"Boucher Brent J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Commercial"}}],"security":"RSUs","published_at":"2020-10-16T17:49:11.000Z","date":"2020-10-14","kind":"grant","acquired":true,"shares":5614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This RSU award was granted to the Reporting Person on October 14, 2020. In accordance with the terms of the RSU award, the award will vest\nas to 2,807 shares on each of October 14, 2021 and October 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This RSU award was granted to the Reporting Person on October 14, 2020. In accordance with the terms of the RSU award, the award will vest\nas to 2,807 shares on each of October 14, 2021 and October 14, 2022."}],"balance_after":5614,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5614},"source":{"system":"sec-edgar","filing":"0001209191-20-055135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919120055135/doc4.xml","form_type":"4"}},{"id":3266373,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":141910,"kind":"person","name":"Boucher Brent J.","position":1,"cik":"0001766229","reported_name":"Boucher Brent J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and GM of Oncology"}}],"security":"Common Stock","published_at":"2020-02-19T00:03:16.000Z","date":"2020-02-12","kind":"tax_withholding","acquired":false,"shares":490,"price":12.99,"value":6365.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 490 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on February 12, 2018."}],"balance_after":15416,"source":{"system":"sec-edgar","filing":"0001567619-20-004259","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920004259/doc1.xml","form_type":"4"}},{"id":3306221,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":141910,"kind":"person","name":"Boucher Brent J.","position":1,"cik":"0001766229","reported_name":"Boucher Brent J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and GM of Oncology"}}],"security":"Common Stock","published_at":"2020-01-21T21:17:37.000Z","date":"2020-01-17","kind":"tax_withholding","acquired":false,"shares":490,"price":15.48,"value":7585.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 490 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on January 17, 2018."}],"balance_after":15906,"source":{"system":"sec-edgar","filing":"0001567619-20-001294","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920001294/doc1.xml","form_type":"4"}},{"id":3390948,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":141910,"kind":"person","name":"Boucher Brent J.","position":1,"cik":"0001766229","reported_name":"Boucher Brent J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and GM of Oncology"}}],"security":"Performance Right","published_at":"2019-10-18T22:23:21.000Z","date":"2019-10-16","kind":"grant","acquired":true,"shares":6452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":6452,"derivative":{"underlying":"Common Stock","underlying_shares":6452},"source":{"system":"sec-edgar","filing":"0001567619-19-019767","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919019767/doc1.xml","form_type":"4"}},{"id":3455852,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":141910,"kind":"person","name":"Boucher Brent J.","position":1,"cik":"0001766229","reported_name":"Boucher Brent J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and GM of Oncology"}}],"security":"Common Stock","published_at":"2019-07-25T20:48:40.000Z","date":"2019-07-18","kind":"tax_withholding","acquired":false,"shares":148,"price":21.53,"value":3186.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 148 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":16396,"source":{"system":"sec-edgar","filing":"0001567619-19-015203","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015203/doc1.xml","form_type":"4"}},{"id":3455851,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":141910,"kind":"person","name":"Boucher Brent J.","position":1,"cik":"0001766229","reported_name":"Boucher Brent J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and GM of Oncology"}}],"security":"Common Stock","published_at":"2019-07-25T20:48:40.000Z","date":"2019-07-18","kind":"tax_withholding","acquired":false,"shares":225,"price":21.53,"value":4844.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 225 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":16544,"source":{"system":"sec-edgar","filing":"0001567619-19-015203","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015203/doc1.xml","form_type":"4"}},{"id":3458424,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":141910,"kind":"person","name":"Boucher Brent J.","position":1,"cik":"0001766229","reported_name":"Boucher Brent J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and GM of Oncology"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-07-20T01:36:35.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":10790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in four equal annual installments beginning on July 17, 2020, such that 25% of the options will vest on each of July 17, 2020, 2021, 2022 and 2023."}],"balance_after":10790,"derivative":{"exercise_price":21.54,"exercise_date":"2020-07-17","expiration_date":"2029-07-17","underlying":"Common Stock","underlying_shares":10790},"source":{"system":"sec-edgar","filing":"0001567619-19-015049","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015049/doc1.xml","form_type":"4"}},{"id":3458423,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":141910,"kind":"person","name":"Boucher Brent J.","position":1,"cik":"0001766229","reported_name":"Boucher Brent J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and GM of Oncology"}}],"security":"Common Stock","published_at":"2019-07-20T01:36:35.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":3226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 3,226 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 3,226 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal installments beginning on July 17, 2020, such that 25% of the restricted stock units will vest on each of July 17, 2020, 2021, 2022 and 2023."}],"balance_after":16769,"source":{"system":"sec-edgar","filing":"0001567619-19-015049","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015049/doc1.xml","form_type":"4"}},{"id":3656127,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":141910,"kind":"person","name":"Boucher Brent J.","position":1,"cik":"0001766229","reported_name":"Boucher Brent J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and GM of Oncology"}}],"security":"Common Stock","published_at":"2019-02-14T23:14:29.000Z","date":"2019-02-12","kind":"tax_withholding","acquired":false,"shares":490,"price":22.9,"value":11221.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 490 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on February 12, 2018."}],"balance_after":13543,"source":{"system":"sec-edgar","filing":"0001567619-19-004544","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919004544/doc1.xml","form_type":"4"}}]}